Previous Close | 6.04 |
Open | 5.96 |
Bid | 6.15 x 100 |
Ask | 6.19 x 400 |
Day's Range | 5.89 - 6.18 |
52 Week Range | 3.15 - 7.67 |
Volume | |
Avg. Volume | 936,752 |
Market Cap | 754.492M |
Beta (5Y Monthly) | -1.17 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.54 |
Earnings Date | May 01, 2024 - May 06, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 13.00 |
CAMBRIDGE, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in two upcoming investor conferences in April. Cantor Virtual Muscular Dystrophy Symposium Date: Wednesday, April 3, 2024Analyst-led fireside chat presentation time: 3:10 p.m.
In this article, we will take a detailed look at Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks. For a quick overview of such stocks, read our article Billionaire Paul Tudor Jones and Insiders Love These 5 Stocks. In an interview given to the Palm Beach Civic Association in January 2024, billionaire Paul Tudor Jones said that […]
Wave Life Sciences Ltd. ( NASDAQ:WVE ) defied analyst predictions to release its annual results, which were ahead of...